Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 86 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market. NeuroDerm Ltd. is a clinical stage pharmaceutical company developing treatments for central nervous system (CNS) disorders.
Jefferies and Cowen and Company acted as joint book-running managers for the offering. Raymond James & Associates and Roth Capital Partners acted as co-managers for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Nir Knoll.
